Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glutaric Acidemia Type II”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableStudy completedNCT00002257
What this trial is testing

Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche 150
Not applicableStudy completedNCT00000995
What this trial is testing

AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT00002222
What this trial is testing

Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche 200
Large-scale testing (Phase 3)Study completedNCT00000688
What this trial is testing

A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 180
Post-approval studies (Phase 4)Study completedNCT00730769
What this trial is testing

Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

Who this might be right for
Cytomegalovirus Infection
Salvador Gil-Vernet 21
Post-approval studies (Phase 4)Study completedNCT01552369
What this trial is testing

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

Who this might be right for
Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 205
Early research (Phase 1)Study completedNCT00000668
What this trial is testing

A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT00002321
What this trial is testing

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Chiron Corporation
Large-scale testing (Phase 3)Study completedNCT00006145
What this trial is testing

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 350
Not applicableStudy completedNCT00002251
What this trial is testing

A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Hoffmann-La Roche 20
Not applicableStudy completedNCT00000989
What this trial is testing

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00001062
What this trial is testing

Ganciclovir in the Treatment of Cytomegalovirus of the Eyes

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT00000766
What this trial is testing

CMV Retinitis Retreatment Trial

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Study completedNCT00031434
What this trial is testing

Valganciclovir in Congenital CMV Infants

Who this might be right for
Cytomegalovirus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00002299
What this trial is testing

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Not applicableUnknownNCT02635269
What this trial is testing

Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy

Who this might be right for
Metabolism, Inborn ErrorsLipid Metabolism, Inborn ErrorsCarbohydrate Metabolism, Inborn Errors+20 more
Rigshospitalet, Denmark 60
Not applicableStudy completedNCT00031421
What this trial is testing

Neonatal CMV-Ganciclovir Follow-up Study

Who this might be right for
Cytomegalovirus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Early research (Phase 1)Study completedNCT00000768
What this trial is testing

Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients

Who this might be right for
ColitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00000691
What this trial is testing

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Next Page